187 related articles for article (PubMed ID: 29498216)
1. Hypertension after kidney donation: Incidence, predictors, and correlates.
Sanchez OA; Ferrara LK; Rein S; Berglund D; Matas AJ; Ibrahim HN
Am J Transplant; 2018 Oct; 18(10):2534-2543. PubMed ID: 29498216
[TBL] [Abstract][Full Text] [Related]
2. GFR ≤25 years postdonation in living kidney donors with (vs. without) a first-degree relative with ESRD.
Matas AJ; Vock DM; Ibrahim HN
Am J Transplant; 2018 Mar; 18(3):625-631. PubMed ID: 28980397
[TBL] [Abstract][Full Text] [Related]
3. Renal Consequences of Diabetes After Kidney Donation.
Ibrahim HN; Berglund DM; Jackson S; Vock DM; Foley RN; Matas AJ
Am J Transplant; 2017 Dec; 17(12):3141-3148. PubMed ID: 28681494
[TBL] [Abstract][Full Text] [Related]
4. Causes and timing of end-stage renal disease after living kidney donation.
Matas AJ; Berglund DM; Vock DM; Ibrahim HN
Am J Transplant; 2018 May; 18(5):1140-1150. PubMed ID: 29369517
[TBL] [Abstract][Full Text] [Related]
5. Implications of excess weight on kidney donation: Long-term consequences of donor nephrectomy in obese donors.
Serrano OK; Sengupta B; Bangdiwala A; Vock DM; Dunn TB; Finger EB; Pruett TL; Matas AJ; Kandaswamy R
Surgery; 2018 Nov; 164(5):1071-1076. PubMed ID: 30149934
[TBL] [Abstract][Full Text] [Related]
6. Association Between Living Kidney Donor Postdonation Hypertension and Recipient Graft Failure.
Holscher CM; Ishaque T; Haugen CE; Jackson KR; Garonzik Wang JM; Yu Y; Al Ammary F; Segev DL; Massie AB
Transplantation; 2020 Mar; 104(3):583-590. PubMed ID: 32106202
[TBL] [Abstract][Full Text] [Related]
7. Living donor postnephrectomy kidney function and recipient graft loss: A dose-response relationship.
Holscher CM; Ishaque T; Garonzik Wang JM; Haugen CE; DiBrito SR; Jackson KR; Muzaale AD; Massie AB; Al Ammary F; Ottman SE; Henderson ML; Segev DL
Am J Transplant; 2018 Nov; 18(11):2804-2810. PubMed ID: 30086198
[TBL] [Abstract][Full Text] [Related]
8. Weight gain after kidney donation: Association with increased risks of type 2 diabetes and hypertension.
Issa N; Sánchez OA; Kukla A; Riad SM; Berglund DM; Ibrahim HN; Matas AJ
Clin Transplant; 2018 Sep; 32(9):e13360. PubMed ID: 30053320
[TBL] [Abstract][Full Text] [Related]
9. Renal Function Profile in White Kidney Donors: The First 4 Decades.
Ibrahim HN; Foley RN; Reule SA; Spong R; Kukla A; Issa N; Berglund DM; Sieger GK; Matas AJ
J Am Soc Nephrol; 2016 Sep; 27(9):2885-93. PubMed ID: 26888476
[TBL] [Abstract][Full Text] [Related]
10. Obesity increases the risk of end-stage renal disease among living kidney donors.
Locke JE; Reed RD; Massie A; MacLennan PA; Sawinski D; Kumar V; Mehta S; Mannon RB; Gaston R; Lewis CE; Segev DL
Kidney Int; 2017 Mar; 91(3):699-703. PubMed ID: 28041626
[TBL] [Abstract][Full Text] [Related]
11. Association of Early Postdonation Renal Function With Subsequent Risk of End-Stage Renal Disease in Living Kidney Donors.
Massie AB; Holscher CM; Henderson ML; Fahmy LM; Thomas AG; Al Ammary F; Getsin SN; Snyder JJ; Lentine KL; Garg AX; Segev DL
JAMA Surg; 2020 Mar; 155(3):e195472. PubMed ID: 31968070
[TBL] [Abstract][Full Text] [Related]
12. Role of Transforming Growth Factor-β in Hypertensive Living Kidney Donors.
Bieniasz M; Kieszek R; Kwapisz M; Jędrzejko K; Durlik M; Pączek L; Kwiatkowski A
Transplant Proc; 2018; 50(6):1602-1604. PubMed ID: 30056868
[TBL] [Abstract][Full Text] [Related]
13. Self-Reported Incident Hypertension and Long-Term Kidney Function in Living Kidney Donors Compared with Healthy Nondonors.
Holscher CM; Haugen CE; Jackson KR; Garonzik Wang JM; Waldram MM; Bae S; Locke JE; Reed RD; Lentine KL; Gupta G; Weir MR; Friedewald JJ; Verbesey J; Cooper M; Segev DL; Massie AB
Clin J Am Soc Nephrol; 2019 Oct; 14(10):1493-1499. PubMed ID: 31537534
[TBL] [Abstract][Full Text] [Related]
14. Patterns of End-Stage Renal Disease Caused by Diabetes, Hypertension, and Glomerulonephritis in Live Kidney Donors.
Anjum S; Muzaale AD; Massie AB; Bae S; Luo X; Grams ME; Lentine KL; Garg AX; Segev DL
Am J Transplant; 2016 Dec; 16(12):3540-3547. PubMed ID: 27287605
[TBL] [Abstract][Full Text] [Related]
15. Recipient Outcomes Following Transplantation of Allografts From Live Kidney Donors Who Subsequently Developed End-Stage Renal Disease.
Muzaale AD; Massie AB; Anjum S; Liao C; Garg AX; Lentine KL; Segev DL
Am J Transplant; 2016 Dec; 16(12):3532-3539. PubMed ID: 27172445
[TBL] [Abstract][Full Text] [Related]
16. Single-Center Long-Term Follow-Up of Kidney Donors in Argentina (Hospital Italiano de Buenos Aires).
Mombelli CA; Giordani MC; Imperiali NC; Groppa SR; Villamil Cortez SK; Schreck CM; Rosa-Diez GJ
Transplant Proc; 2018 Mar; 50(2):418-422. PubMed ID: 29579818
[TBL] [Abstract][Full Text] [Related]
17. Increase in 24-Hour Protein Excretion Immediately After Donation Is Associated With Decreased Functional Recovery in Living Kidney Donors.
Na JC; Yoon MG; Lee HH; Yoon YE; Kim DG; Huh KH; Kim YS; Han WK
Transplant Proc; 2019 Oct; 51(8):2543-2548. PubMed ID: 31473006
[TBL] [Abstract][Full Text] [Related]
18. Increasing Use of the Expanded Criteria for Living Kidney Donation and Good Outcomes of Living Kidney Donors in Korea.
Lim HJ; Jambaldorj E; Lee Y; Kang SS; Koo TY; Ahn C; Yang J
Transplant Proc; 2016 Sep; 48(7):2407-2411. PubMed ID: 27742310
[TBL] [Abstract][Full Text] [Related]
19. Intermediate Renal Outcomes, Kidney Failure, and Mortality in Obese Kidney Donors.
Ibrahim HN; Murad DN; Hebert SA; Adrogue HE; Nguyen H; Nguyen DT; Matas AJ; Graviss EA
J Am Soc Nephrol; 2021 Nov; 32(11):2933-2947. PubMed ID: 34675059
[TBL] [Abstract][Full Text] [Related]
20. Risk of end-stage renal disease following live kidney donation.
Muzaale AD; Massie AB; Wang MC; Montgomery RA; McBride MA; Wainright JL; Segev DL
JAMA; 2014 Feb; 311(6):579-86. PubMed ID: 24519297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
